|
|
Post by dreamboatcruise on Oct 18, 2017 13:41:34 GMT -5
The granting of a European patent for MNKD today may help with partnership opportunities. imhop. Though at the recent Cantor conference MNKD presented a slide showing the "targeted" countries around the world and the EU region was not shown as being targeted. |
|
|
|
Post by sportsrancho on Oct 18, 2017 13:41:47 GMT -5
Been buying small lots all day. That’s what Wells says. Have to wait till it settles tomorrow. One order bid at 1.00. Then put in for .45. Then a market just to see... 2019 strike 10 traded between .60 and .80 2020 - between 1 and 1.10 Unless u bought 2020’s when MNKD was trading under 4 I just bought more and looked again and it says estimated price .99 cents |
|
|
|
Post by liane on Oct 18, 2017 13:45:42 GMT -5
2020's were not yet trading when s/p was under 4.
|
|
|
|
Post by ghochr on Oct 18, 2017 13:50:48 GMT -5
2020's were not yet trading when s/p was under 4. That’s why I was wondering how she averaged at .85 |
|
|
|
Post by sportsrancho on Oct 18, 2017 13:58:05 GMT -5
2020's were not yet trading when s/p was under 4. That’s why I was wondering how she averaged at .85 |
|
|
|
Post by MnkdWASmyRtrmntPlan on Oct 18, 2017 16:16:16 GMT -5
|
|
|
|
Post by dreamboatcruise on Oct 18, 2017 16:27:15 GMT -5
I haven't looked into this in detail but this is likely the same as a patent already received in the US. It may have simply been delayed by EU taking longer to review or having issues that they required MNKD to address. To me I don't see anything surprising about it. A company, unless incredibly cash poor, would spend the money to have a key patent approved in major markets around the world even if they have no immediate plans to go into those markets... because if you don't do it within a very limited time frame you lose the ability to file. Chalk this up to very normal business practice and a very predictable outcome... e.g. nothing to see here. |
|
